Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
Clinical benefits of tramiprosate in Alzheimer's disease are associated with higher number of APOE4 alleles: the "APOE4 gene-dose effect"
J Prev Alzheimers Dis · Vol. 3, pp. 219-228 Published January 1, 2016
More on these topics
Browse all publications →-
2017 · Alzheimer's & Dementia
[O5-01-02]: RATIONALE FOR SELECTION OF PRIMARY ENDPOINTS IN THE ALZHEIMER PREVENTION INITIATIVE GENERATION STUDY IN COGNITIVELY HEALTHY APOE4 HOMOZYGOTES
-
2016 · J Prev Alzheimers Dis
A novel eigenvector-based method to detect mild Alzheimer's disease using event-related potentials
-
2011 · Alzheimer's & Dementia
P3-287: Composite cognitive endpoints with improved power to detect presymptomatic Alzheimer's disease treatment effects: Findings in the Colombian kindred with the E280A Presenilin 1 mutation and the Alzheimer's Prevention Initiative
-
2011 · Alzheimer's & Dementia
03-03-02: Composite cognitive endpoints with improved power to detect presymptomatic Alzheimer's disease treatment effects in APOE4 carriers: Findings from the Alzheimer's prevention initiative